Request for Proposal For Manufacturing Of Affordably Priced, Quality-Assured Ferric Carboxymaltose (Fcm) For Use In Low- And Middle-Income Countries (Lmics)

Request for proposals for Manufacturing of Affordably Priced, Quality-Assured Ferric Carboxymaltose (FCM) for Use in Low- and Middle-Income Countries (LMICs) Manufacturers of Ferric Carboxymaltose (Fcm), an Intravenous Iron Product Clinically Proven as a Safe and Effective Treatment for Pregnant Women with Anemia across Diverse Populations. SUPREME-SECURE is a Unitaid-funded program working to strengthen sustainable access to quality-assured diagnostics and treatments for preeclampsia, eclampsia, and maternal anemia in sub-Saharan Africa. CHAI is leading this initiative in partnership with Concept Foundation, Aurum Institute, Burnet Institute, and WACI Health. As part of the programs market access work, CHAI is now accepting proposals from manufacturers of ferric carboxymaltose (FCM), an intravenous iron product clinically proven as a safe and effective treatment for pregnant women with anemia across diverse populations. Key dates · RFP information session: July 2, 2026 (Register here) · Proposal submission deadline: July 24, 2026 Target countries include Ghana, Kenya, Malawi, Nigeria, Senegal, and Tanzania, with potential for broader low- and middle-income country (LMIC) reach. Selected manufacturers may receive technical assistance and/or financial support to accelerate development, approval, and supply. Tender Link : https://www.clintonhealthaccess.org/resource-center/?_sft_category=rfp&sort_order=date+desc